Insight Molecular Diagnostics (IMDX) Total Debt Growth (3y) (2020 - 2026)
Insight Molecular Diagnostics (IMDX) Total Debt Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 5.73% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 9.22% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -39.51% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 7.07% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 5.11% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | -4.73% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -12.66% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | -0.64% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 5.13% |
| 10 | Insight Molecular Diagnostics | 158.03 Mn | 139.50 Mn | 157,000.00 | 86.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 86.41% |
| Mar 31, 2026 | 13.41% |
| Dec 31, 2025 | 57.76% |
| Sep 30, 2025 | 113.18% |
| Jun 30, 2025 | 4.20% |
| Mar 31, 2025 | -22.91% |
| Dec 31, 2024 | -45.23% |
| Sep 30, 2024 | -36.64% |
| Dec 31, 2023 | -15.96% |
| Sep 30, 2023 | -70.22% |
| Jun 30, 2023 | -70.16% |
| Mar 31, 2023 | -67.11% |
| Dec 31, 2022 | -66.99% |
| Sep 30, 2022 | -42.62% |
| Jun 30, 2022 | -7.48% |
| Mar 31, 2022 | -0.49% |
| Dec 31, 2021 | 6.56% |
| Sep 30, 2021 | 21.95% |
| Jun 30, 2021 | 100.94% |
| Mar 31, 2021 | 27.89% |